-
1دورية أكاديمية
المؤلفون: Glaviano, Antonino, Foo, Aaron S. C., Lam, Hiu Y., Yap, Kenneth C. H., Jacot, William, Jones, Robert H., Eng, Huiyan, Nair, Madhumathy G., Makvandi, Pooyan, Geoerger, Birgit, Kulke, Matthew H., Baird, Richard D., Prabhu, Jyothi S., Carbone, Daniela, Pecoraro, Camilla, Teh, Daniel B. L., Sethi, Gautam, Cavalieri, Vincenzo, Lin, Kevin H., Javidi-Sharifi, Nathalie R.
المصدر: Molecular Cancer; 11/23/2023, Vol. 22 Issue 1, p1-37, 37p
مصطلحات موضوعية: CELLULAR signal transduction, CANCER treatment, MTOR inhibitors, CELL cycle, TRANSCRIPTION factors
-
2دورية أكاديمية
المؤلفون: Antonino Glaviano, Aaron S. C. Foo, Hiu Y. Lam, Kenneth C. H. Yap, William Jacot, Robert H. Jones, Huiyan Eng, Madhumathy G. Nair, Pooyan Makvandi, Birgit Geoerger, Matthew H. Kulke, Richard D. Baird, Jyothi S. Prabhu, Daniela Carbone, Camilla Pecoraro, Daniel B. L. Teh, Gautam Sethi, Vincenzo Cavalieri, Kevin H. Lin, Nathalie R. Javidi-Sharifi, Eneda Toska, Matthew S. Davids, Jennifer R. Brown, Patrizia Diana, Justin Stebbing, David A. Fruman, Alan P. Kumar
المصدر: Molecular Cancer, Vol 22, Iss 1, Pp 1-37 (2023)
مصطلحات موضوعية: PI3K/AKT/mTORC pathway, Pan PI3K inhibitors, Isoform-specific PI3K inhibitors, Dual PI3K/mTOR inhibitors, AKT inhibitors, Allosteric mTOR inhibitors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1476-4598Test
-
3دورية أكاديمية
المؤلفون: Ahlem Jebali, Nicolas Dumaz
المصدر: Molecular Cancer, Vol 17, Iss 1, Pp 1-10 (2018)
مصطلحات موضوعية: EGFR, HER2, mTOR, mTOR inhibitors, mTORC2, PDGFR, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://link.springer.com/article/10.1186/s12943-018-0794-0Test; https://doaj.org/toc/1476-4598Test
-
4دورية أكاديمية
المؤلفون: Hua-fu Zhao, Jing Wang, Wei Shao, Chang-peng Wu, Zhong-ping Chen, Shing-shun Tony To, Wei-ping Li
المصدر: Molecular Cancer; 6/7/2017, Vol. 16, p1-16, 16p, 1 Diagram, 3 Charts
مصطلحات موضوعية: GLIOBLASTOMA multiforme treatment, PHOSPHATIDYLINOSITOL 3-kinases, MTOR inhibitors, PROTEIN kinase inhibitors, NEOVASCULARIZATION, THERAPEUTICS
-
5
المؤلفون: Ji Nie, Xuelei Ma, Jing Yang, Xiawei Wei, Yong Peng, Yuquan Wei
المصدر: Molecular Cancer
Molecular Cancer, Vol 18, Iss 1, Pp 1-28 (2019)مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Antineoplastic Agents, Review, Biology, lcsh:RC254-282, PI3K signaling, PI3K, Target therapy, 03 medical and health sciences, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Neoplasms, medicine, Animals, Humans, Molecular Targeted Therapy, Protein kinase B, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, Cancer, Phosphoinositide-3 Kinase Inhibitors, Clinical Trials as Topic, TOR Serine-Threonine Kinases, Master regulator, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Discovery and development of mTOR inhibitors, Clinical trial, Gene Expression Regulation, Neoplastic, 030104 developmental biology, Oncology, Tumor progression, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, mTOR, Molecular Medicine, Proto-Oncogene Proteins c-akt, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760fbcdfb07da0c9e7201f544add6b61Test
http://europepmc.org/articles/PMC6379961Test